These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 26130307)
1. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma. Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307 [TBL] [Abstract][Full Text] [Related]
2. [Preliminary findings for metabolite profiles of papillary thyroid carcinoma and laryngeal squamous cell carcinoma]. Fei MJ; Xu YN; Wang JD Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 31(20):1561-1565. PubMed ID: 29797950 [No Abstract] [Full Text] [Related]
3. [The characteristic of metabolics of female papillary thyroid carcinoma and its relationship with primary tumor size and cervical lymph node metastases]. Zheng WJ; Xu YN; Zhou QY; Chen J; Fei MJ; Wang JD Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 51(2):105-11. PubMed ID: 26898866 [TBL] [Abstract][Full Text] [Related]
4. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747 [TBL] [Abstract][Full Text] [Related]
5. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study. Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373 [TBL] [Abstract][Full Text] [Related]
6. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy. Shang X; Zhong X; Tian X Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059 [TBL] [Abstract][Full Text] [Related]
7. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma. Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis. Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390 [TBL] [Abstract][Full Text] [Related]
9. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma. Shen CT; Zhang Y; Liu YM; Yin S; Zhang XY; Wei WJ; Sun ZK; Song HJ; Qiu ZL; Wang CR; Luo QY Clin Endocrinol (Oxf); 2017 Dec; 87(6):844-852. PubMed ID: 28755525 [TBL] [Abstract][Full Text] [Related]
11. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI Berinde GM; Socaciu AI; Socaciu MA; Petre GE; Socaciu C; Piciu D Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542465 [TBL] [Abstract][Full Text] [Related]
12. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [TBL] [Abstract][Full Text] [Related]
13. Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study. Caria P; Tronci L; Dettori T; Murgia F; Santoru ML; Griffin JL; Vanni R; Atzori L Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262749 [TBL] [Abstract][Full Text] [Related]
14. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer. Liang Q; Wang C; Li B Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916 [TBL] [Abstract][Full Text] [Related]
15. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma. Wang Z; Yang Y; Xing Y; Si D; Wang S; Lin J; Li C; Zhang J; Yin D Sci Rep; 2023 Oct; 13(1):17666. PubMed ID: 37848492 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach. Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583 [TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985 [TBL] [Abstract][Full Text] [Related]
19. Metabolic Profiling with Gas Chromatography-Mass Spectrometry and Capillary Electrophoresis-Mass Spectrometry Reveals the Carbon-Nitrogen Status of Tobacco Leaves Across Different Planting Areas. Zhao J; Zhao Y; Hu C; Zhao C; Zhang J; Li L; Zeng J; Peng X; Lu X; Xu G J Proteome Res; 2016 Feb; 15(2):468-76. PubMed ID: 26784525 [TBL] [Abstract][Full Text] [Related]
20. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells. Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]